Does the patient have clinical cardiovascular disease?
Does the patient have type 2 diabetes?
Yes NoIs the patient's A1C above target?
Yes NoDoes the patient have clinical microvascular disease?
What is the patient's age?
yearsSubmitHow long has the patient been diagnosed with diabetes?
yearsSubmitDoes the patient have at least one of the following risk factor for cardiovascular disease?
DRUG CLASS | RECOMMENDATION | CAUTIONS |
---|---|---|
Statin |
YES |
Potentially embryopathic – discontinue prior to conception. |
ACEi / ARB |
YES |
Potentially embryopathic – discontinue prior to conception (used to treat hypertension) or upon detection of pregnancy (used to treat CKD). |
ASA |
YES |
|
Liraglutide, Empagliflozin or Canagliflozin |
YES |
No safety data – discontinue prior to conception. |
DRUG CLASS | RECOMMENDATION | CAUTIONS |
---|---|---|
Statin |
YES |
Potentially embryopathic – discontinue prior to conception. |
ACEi / ARB |
YES |
Potentially embryopathic – discontinue prior to conception (used to treat hypertension) or upon detection of pregnancy (used to treat CKD). |
ASA |
YES |
|
DRUG CLASS | RECOMMENDATION | CAUTIONS |
---|---|---|
Statin |
YES |
Potentially embryopathic – discontinue prior to conception. |
ACEi / ARB |
YES |
Potentially embryopathic – discontinue prior to conception (used to treat hypertension) or upon detection of pregnancy (used to treat CKD). |
ASA |
Not routinely recommended |
|
DRUG CLASS | RECOMMENDATION | CAUTIONS |
---|---|---|
Statin |
YES |
Potentially embryopathic – discontinue prior to conception. |
ACEi / ARB |
NOMay be indicated for BP control |
|
ASA |
Not routinely recommended |
|
DRUG CLASS | RECOMMENDATION | CAUTIONS |
---|---|---|
Statin |
NOMay be indicated per CCS guidelines |
|
ACEi / ARB |
NOMay be indicated for BP control |
|
ASA |
Not routinely recommended |
|
Next step: download and complete a Prescription for Cardiovascular Protection with Diabetes
Prescription for Cardiovascular Protection with Diabetes:Download PDF
Risk Assessment Algorithm:Download PDF
Additional Resources: Canadian Cardiovascular Society (CCS) Guideline Resources